Ending coverage of the drugs for obesity in 2026 is expected to save the state hundreds of millions of dollars over the next few years
This is especially important for anyone with: A personal or family history of medullary thyroid carcinoma MEN 2 Pancreatitis history Gallbladder disease Kidney problems Severe gastrointestinal disease or gastroparesis Diabetes medications that may cause hypoglycemia Pregnancy plans or breastfeeding Upcoming surgery or procedures requiring anesthesia Multiple prescriptions or supplements Prior severe reactions to weight loss medications Medical screening helps determine whether a medication is appropriate and how it should be monitored
Some patients may benefit from very low-calorie diets (800 kcal/day) under medical supervision, particularly those with type 2 diabetes or significant obesity-related complications, as outlined in NICE CG189
It is always best to consult with your doctor before starting any new supplement during this time
Xu G, Hansen JS, Zhao XJ, Chen S, Hoene M, Wang XL, et al
doi: 10.1038/ni.3133 19 KorneliusE.HuangJ
